Expression and Functionality of Connexin-Based Channels in Human Liver Cancer Cell Lines
- PMID: 34830068
- PMCID: PMC8623148
- DOI: 10.3390/ijms222212187
Expression and Functionality of Connexin-Based Channels in Human Liver Cancer Cell Lines
Abstract
Liver cancer cell lines are frequently used in vitro tools to test candidate anti-cancer agents as well as to elucidate mechanisms of liver carcinogenesis. Among such mechanisms is cellular communication mediated by connexin-based gap junctions. The present study investigated changes in connexin expression and gap junction functionality in liver cancer in vitro. For this purpose, seven human liver cancer cell lines, as well as primary human hepatocytes, were subjected to connexin and gap junction analysis at the transcriptional, translational and activity level. Real-time quantitative reverse transcription polymerase chain reaction analysis showed enhanced expression of connexin43 in the majority of liver cancer cell lines at the expense of connexin32 and connexin26. Some of these changes were paralleled at the protein level, as evidenced by immunoblot analysis and in situ immunocytochemistry. Gap junctional intercellular communication, assessed by the scrape loading/dye transfer assay, was generally low in all liver cancer cell lines. Collectively, these results provide a full scenario of modifications in hepatocyte connexin production and gap junction activity in cultured liver cancer cell lines. The findings may be valuable for the selection of neoplastic hepatocytes for future mechanistic investigation and testing of anti-cancer drugs that target connexins and their channels.
Keywords: cell line; connexin; gap junction; in vitro; liver cancer.
Conflict of interest statement
The authors declare no conflict of interest.
Figures







Similar articles
-
Connexin-Based Channel Activity Is Not Specifically Altered by Hepatocarcinogenic Chemicals.Int J Mol Sci. 2021 Oct 29;22(21):11724. doi: 10.3390/ijms222111724. Int J Mol Sci. 2021. PMID: 34769157 Free PMC article.
-
Signal transduction of gap junctional genes, connexin32, connexin43 in human hepatocarcinogenesis.World J Gastroenterol. 2003 May;9(5):946-50. doi: 10.3748/wjg.v9.i5.946. World J Gastroenterol. 2003. PMID: 12717835 Free PMC article.
-
The relationship between connexins, gap junctions, tissue architecture and tumour invasion, as studied in a novel in vitro model of HPV-16-associated cervical cancer progression.Oncogene. 2003 Sep 11;22(39):7969-80. doi: 10.1038/sj.onc.1206709. Oncogene. 2003. PMID: 12970745
-
Connexin expression and gap junctions in the mammary gland.Cell Biol Int. 1996 Feb;20(2):121-5. doi: 10.1006/cbir.1996.0016. Cell Biol Int. 1996. PMID: 8935156 Review.
-
Structure, Regulation and Function of Gap Junctions in Liver.Cell Commun Adhes. 2015 Apr-Dec;22(2-6):29-37. doi: 10.3109/15419061.2016.1151875. Epub 2016 Mar 22. Cell Commun Adhes. 2015. PMID: 27001459 Free PMC article. Review.
Cited by
-
Influence of C60 Nanofilm on the Expression of Selected Markers of Mesenchymal-Epithelial Transition in Hepatocellular Carcinoma.Cancers (Basel). 2023 Nov 23;15(23):5553. doi: 10.3390/cancers15235553. Cancers (Basel). 2023. PMID: 38067256 Free PMC article.
-
Polyhydroxylated Fullerene C60(OH)40 Nanofilms Promote the Mesenchymal-Epithelial Transition of Human Liver Cancer Cells via the TGF-β1/Smad Pathway.J Inflamm Res. 2023 Aug 29;16:3739-3761. doi: 10.2147/JIR.S415378. eCollection 2023. J Inflamm Res. 2023. PMID: 37663761 Free PMC article.
-
GJB2 as a novel prognostic biomarker associated with immune infiltration and cuproptosis in ovarian cancer.Apoptosis. 2025 Jun;30(5-6):1589-1613. doi: 10.1007/s10495-025-02119-8. Epub 2025 May 15. Apoptosis. 2025. PMID: 40375037 Free PMC article.
-
Intracellular Ca2+ waves in mammalian cells.Biol Futur. 2025 Sep;76(3):293-313. doi: 10.1007/s42977-025-00270-6. Epub 2025 Jun 29. Biol Futur. 2025. PMID: 40581908 Review.
-
The prognostic value and biological significance of gap junction beta protein 2 (GJB2 or Cx26) in cervical cancer.Front Oncol. 2022 Jul 21;12:907960. doi: 10.3389/fonc.2022.907960. eCollection 2022. Front Oncol. 2022. PMID: 35936685 Free PMC article.
References
-
- Collins S.D., Yuen G., Tu T., Budzinska M.A., Spring K., Bryant K., Shackel N.A. In vitro models of the liver: Disease modeling, drug discovery and clinical applications. In: Tirnitz-Parker J.E.E., editor. Hepatocellular Carcinoma. Codon Publications; Brisbane, Australia: 2019. - PubMed
MeSH terms
Substances
Grants and funding
- 18/10953-9/São Paulo Research Foundation
- G0F7219N/Fund for Scientific Research-Flanders
- 1270 310557/2019-4/National Council for Scientific and Technological Development
- Brasil Finance code 001/Coordenação de Aperfeicoamento de Pessoal de Nível Superior
- Alternatives Research and Development Foundation
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous